Morphine, pethidine and fentanyl have similar pharmacokinetic profiles with moderately long elimination half-lives (3 to 4 hours), large steady-state volumes of distribution (2 to 4I1kg), and high hepatic clearances (10 to 20 mllkg/min). Alfentanil has a shorter terminal elimination halflife (10 hours) because of a decreased steady-state volume of distribution (0.5 to I IIkg). Physicochemical properties and blood:brain tissue solubility can explain the clinical differences in the rate of onset and dissipation of narcotic effect for these four narcotics. Morphine's low lipid solubility and limited rate of blood:brain barrier penetration results in the slow onset and dissipation of narcotic effect relative to pethidine or fentanyl. A Ifentanil's lower blood.·brain solubility results in the very rapid onset of narcotic effect when compared to fentanyl. All of the narcotics have a very steep blood concentration:narcotic effect curves. Thus, small changes of narcotic blood concentrations can have profound changes of narcotic effect. Finally, different degrees of perioperative stimuli result in different narcotic blood concentration requirements. Thus, narcotic infusion rales need be varied during surgical procedures to adjust for the varying opiate requirement.
Narcotics have numerous clinical applications in anaesthetic practice. They are used to premedicate patients, supplement the weak (nitrous oxide) and potent (halothane, enflurane, isoflurane) inhalational anaesthetics, provide complete anaesthesia in very high doses (cardiac surgery), and treat postoperative pain. The narcotics that are used clinically range from very old drugs such as morphine and pethidine (meperidine) to the newer synthetic opiates like fentanyl and *M.D., Associate Professor of Ancsthcsia and Medicine (Clinical Pharmacology), Stanford University School of Medicine. Staff Anesthesiologist, Anesthcsiology Service. Veterans Administration ~·tedical CenlCf. SUPPorled by the National Institute of Aging (ROl-AG-04594, POI-AG-03104). the Veterans Administration Research Grants, and the Anesthesia/Pharmaco]ogy Research Foundation alfentanil. There have been numerous reviews of the clinical pharmacology of narcotics in anaesthetic practice. 1·5 This article summarises the pharmacokinetic profiles of four commonly used narcotics: morphine, pethidine, fentanyl and alfentanil. The clinical effects of these narcotics are examined relative to their pharmacokinetics and' physicochemical properties. New concepts of narcotic pharmacodynamics are developed along with the rationale for narcotic infusion during and after anaesthesia.
COMPARATIVE PHARMACOKINETICS

Morphine, pethidine, fentanyl and alfentanil
Morphine (0.1 mg/kg) and pethidine (l mg/kg) have a long duration of narcotic effect (2 to 4 hours) relative to fentanyl (10 I-Ig/kg), which lasts one-half to one hour. Alfentanil (50 Jig/kg), a new fentanyl derivative, has an even shorter duration of narcotic effect (15 to 30 minutes). Pharmacokinetic principles can readily explain the differences between these four narcotics. Morphine, pethidine and fentanyl share similar pharmacokinetic properties (Table 1) . They have a large steadystate volume of distribution, high hepatic clearance, and a relatively long terminal elimination half-life. The slow rate of elimination from the body may explain morphine's and pethidine's long duration of effect but not fentanyl's short duration of effect. Fentanyl differs from morphine and pethidine in having very high lipid solubility ( Table 2 ). This facilitates rapid entry and exit from the brain; thus, fentanyl can rapidly redistribute from brain to muscle and fat tissues. Hence, fentanyl's short duration of effect is analogous in mechanism to the redistribution that governs thiopentone's termination of effect. 6 As the fentanyl dose is increased, either as a single large dose or multiple repeated bolus administrations, the duration of fentanyl's narcotic effect will progressively increase and begin to resemble that of morphine or pethidine. 7 
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Alfentanil Alfentanil has a different pharmacokinetic profile (Table 1) . It has a lower clearance and volume of distribution and, thus, a shorter terminal elimination half-life. Its shorter duration of narcotic effect is due to two factors. First, there is more rapid redistribution of a small dose of alfentanil to subtherapeutic concentration relative to an equipotent dose of fentanyl.8 Second, the volume of distribution is small so that the terminal elimination half-life is short. Thus, small bolus intravenous injections of alfentanil should have significant utility in clinical anaesthesia for short surgical procedures and a continuous infusion should be suitable for longer procedures.
NARCOTIC PHARMACODYNAMICS
As previously discussed, alfentanil has a different pharmacokinetic profile from fentanyl. The shorter terminal elimination halflife does not explain the distinctly different clinical profile of alfentanil -more rapid onset of narcotic effect, more rapid recovery at low and high doses compared with fentanyl. Using the electroencephalogram (EEG) as a sensitive measure of the fentanyllalfentanil drug effect, Scott et al. 9 have compared the pharmacodynamics of these narcotics in man. Alfentanil's more rapid onset of narcotic effect can be clearly seen with the EEG. The half-time of blood:brain equilibration (hysteresis) is approximateiy one minute for alfentanil and six minutes for fentanyl. This difference in blood:brain equilibration may be due to a lower solubility of alfentanil in brain relative to fe'ntanyl. This difference in blood:brain equilibration along with alfentanil's shorter terminal elimination half-life results in other important pharmacokinetic/dynamic differences. As the dose of fentanyl increases, the duration of narcotic effect becomes longer. As the redistribution becomes less effective in lowering the fentanyl blood levels with high doses, the duration of drug effect becomes proportionally greater relative to the given dose. With alfentanil, there is a much more linear relationship between the increase of dose and duration of narcotic effect.
Mather and colleagues 10 -12 have carefully examined the relationship between postoperative analgesia and pethidine blood concentrations. They found that the change of pethidine blood concentration needed to go NARCOTIC KINETICS/DYNAMICS from no analgesia (pain) to good analgesia (no pain) was very small -a very steep concentration-response curve. IO They also found that there was a great deal of variability between patients as to the pethidine blood concentrations which finally achieved analgesia. They found the blood concentration of pethidine to be extremely variable after intramuscular administration, and frequently, therapeutic blood concentrations were never achieved. In a subsequent study,11 they demonstrated that with continuous intravenous infusion of pethidine for 24 to 36 hours, therapeutic levels could consistently be achieved and complete analgesia maintained. The implication of this research is that the method of administering the narcotic is more important than the type of narcotic used. Better postoperative analgesia can be achieved with methods that deliver continuous, stable blood concentrations of the narcotic.
Narcotics, specifically fentanyl and morphine, are given in large doses as the sole anaesthetic agent in cardiovascular anaesthesia. Stanley and colleagues l3 have popularised the concept of high-dose fentanyl (up to 150 J-Ig/kg) for cardiovascular anaesthesia, claiming stable cardiovascular pharmacodynamics. M urphy and Hug l4 have shown there is a ceiling to the degree in which fentanyl can decrease the MAC of enflurane in dogs. Thus, animal data suggests that narcotics are not complete anaesthetics and that beyond certain concentrations more anaesthetic effect is not possible. Wynands et al. 15 have confirmed this in man. Using moderate to large doses of fentanyl as infusions or bolus injections, they found that in approximately 20070 of patients with good ventricular function having coronary surgery, high fentanyl concentrations (>20 ng/ml) still resulted in haemodynamic responses (20070 increase of systolic blood pressure). This animal and human data suggests that narcotics are not complete anaesthetics and that very high doses that cause postoperative ventilatory depression do not necessarily cause better anaesthetic states.
Defining therapeutic blood concentrations of narcotics for clinically relevant effects is difficult. Measurement of pain is very subjective and can be influenced by many factors. 16 Quantitation of narcotic-induced Anaesthesia and Inrensive Care, Vo!. 15, No. /, February, 1987 ventilatory depression can also be complex with numerous, different measurement techniques to be considered. li Inability to quantitate the contribution of other residual anaesthetic drugs that effect ventilation besides the narcotic of interest (i.e., inhalational or intravenous anaesthetics) limits the scientific interpretation of ventilatory depression data collected in the clinical setting. Finally, anaesthesiologists frequently cannot precisely define an 'adequate' clinical anaesthetic state.
The muscle paralysis that accompanies narcotic anaesthesia removes the movement response that is associated with the MAC concept and inhalational anaesthetics. Haemodynamic response (tachycardia, hypertension) and autonomic symptoms (tearing, sweating) are used clinically to indicate an inadequate depth of anaesthesia. Table 3 indicates the therapeutic windows of common clinical narcotic end points used in anaesthesia. The therapeutic window is defined as the range of blood or plasma concentrations in which the indicated narcotic effect has been obtained. The values in Table 3 represent a distillation of numerous investigative sources. The therapeutic windows of alfentanil have been defined with much more scientific rigor than the data available for fentanyl. 18 From Table 3 , it emerges that different perioperative stimuli require different levels of narcotic. Adequate anaesthesia can be achieved with massive doses of fentanyl or alfentanil, but adequate ventilation will not be possible because the narcotic plasma concentrations will be excessive at the end of the surgical procedure. Alfentanil's rapid blood:brain equilibration and short elimination half-life make it an ideal narcotic to be used as a variable-rate infusion, titrated to the clinical response. 19 The pharmacokinetic profiles of narcotic analgesics have been well defined. The pharmacodynamics or therapeutic plasma concentrations require more rigorous investigation to provide the clinical and scientific basis of using narcotic infusions in the perioperative period.
